Effect of 5 mg of Oxybutynin and 6 mg of Reboxetine on obstructive sleep apnea severity
M. Berger (Lausanne, Switzerland), R. Dussez (Lausanne, Switzerland), N. Marchi (Lausanne, Switzerland), G. Solelhac (Lausanne, Switzerland), B. Bradley (Lausanne, Switzerland), G. Lecciso (Lausanne, Switzerland), J. Haba-Rubio (Lausanne, Switzerland), F. Siclari (Lausanne, Switzerland), R. Heinzer (Lausanne, Switzerland)
Source: International Congress 2022 – Sleep-disordered breathing treatment: from lifestyle to CPAP and beyond
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Berger (Lausanne, Switzerland), R. Dussez (Lausanne, Switzerland), N. Marchi (Lausanne, Switzerland), G. Solelhac (Lausanne, Switzerland), B. Bradley (Lausanne, Switzerland), G. Lecciso (Lausanne, Switzerland), J. Haba-Rubio (Lausanne, Switzerland), F. Siclari (Lausanne, Switzerland), R. Heinzer (Lausanne, Switzerland). Effect of 5 mg of Oxybutynin and 6 mg of Reboxetine on obstructive sleep apnea severity. 3601
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|